STOCK TITAN

KORU Medical Systems to Participate in Piper Sandler’s 36th Annual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

KORU Medical Systems (NASDAQ: KRMD), a medical technology company specializing in large volume subcutaneous infusion solutions, has announced its participation in Piper Sandler's 36th Annual Healthcare Conference. The Company's management will present on December 5, 2024, at 11:00 am ET. Investors and interested parties can access both the live and archived webcast through the News/Events page in the Investors section of KORU Medical's website.

KORU Medical Systems (NASDAQ: KRMD), un'azienda di tecnologia medica specializzata in soluzioni di infusione sottocutanea ad alto volume, ha annunciato la sua partecipazione alla 36a Conferenza Sanitaria Annuale di Piper Sandler. La direzione dell'azienda presenterà il 5 dicembre 2024, alle 11:00 ET. Gli investitori e le parti interessate possono accedere sia alla diretta che alla registrazione del webcast attraverso la pagina News/Eventi nella sezione Investitori del sito web di KORU Medical.

KORU Medical Systems (NASDAQ: KRMD), una empresa de tecnología médica especializada en soluciones de infusión subcutánea de gran volumen, ha anunciado su participación en la 36a Conferencia Anual de Salud de Piper Sandler. La dirección de la empresa presentará el 5 de diciembre de 2024, a las 11:00 a.m. ET. Los inversores y partes interesadas pueden acceder tanto a la transmisión en vivo como al webcast archivado a través de la página de Noticias/Eventos en la sección de Inversores del sitio web de KORU Medical.

KORU Medical Systems (NASDAQ: KRMD), 대용량 피하 주입 솔루션을 전문으로 하는 의료 기술 회사가 Piper Sandler의 제36회 연례 의료 회의에 참가한다고 발표했습니다. 회사의 경영진은 2024년 12월 5일 오전 11:00 ET에 발표할 예정입니다. 투자자 및 관심 있는 분들은 KORU Medical 웹사이트의 투자자 섹션에 있는 뉴스/이벤트 페이지를 통해 생중계 및 아카이브된 웹캐스트를 모두 이용할 수 있습니다.

KORU Medical Systems (NASDAQ: KRMD), une entreprise de technologie médicale spécialisée dans les solutions d'infusion sous-cutanée à volume élevé, a annoncé sa participation à la 36e Conférence Annuelle de Santé de Piper Sandler. La direction de l'entreprise présentera le 5 décembre 2024, à 11h00 ET. Les investisseurs et les parties intéressées peuvent accéder à la fois au webcast en direct et à l'archivage via la page News/Events de la section Investisseurs du site web de KORU Medical.

KORU Medical Systems (NASDAQ: KRMD), ein Medizintechnikunternehmen, das sich auf große subkutane Infusionslösungen spezialisiert hat, hat seine Teilnahme an der 36. jährlichen Gesundheitskonferenz von Piper Sandler bekannt gegeben. Das Management des Unternehmens wird am 5. Dezember 2024 um 11:00 Uhr ET präsentieren. Investoren und Interessierte können sowohl auf den Live- als auch auf die archivierte Webcast über die Seite News/Events im Bereich Investoren der Website von KORU Medical zugreifen.

Positive
  • None.
Negative
  • None.

MAHWAH, N.J.--(BUSINESS WIRE)-- KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will participate in Piper Sandler’s 36th Annual Healthcare Conference on December 5, 2024.

KORU Medical's management is scheduled to present at Piper Sandler’s 36th Annual Healthcare Conference on December 5, 2024, at 11:00 am ET. Interested parties can access the live and archived webcast on the News/Events page of the Investors section of KORU Medical’s website at www.korumedical.com.

About KORU Medical Systems

KORU Medical develops, manufactures, and commercializes innovative and patient-centric large volume subcutaneous infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System (“the FREEDOM System”) currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. The Freedom System, which received its first FDA clearance in 1994, is used for self-administration in the home by the patient and/or delivery in an ambulatory infusion center by a healthcare professional. Through its Novel Therapies business, KORU Medical provides products for use by biopharmaceutical companies in feasibility/clinical trials during the drug development process and, as needed, is capable of customizing the Freedom System for clinical and commercial use across multiple drug categories. For more information, please visit www.korumedical.com.

Investor Contact:

Greg Chodaczek

347-620-7010

investor@korumedical.com

Source: KORU Medical Systems

FAQ

When will KORU Medical Systems (KRMD) present at Piper Sandler's Healthcare Conference?

KORU Medical Systems will present at Piper Sandler's 36th Annual Healthcare Conference on December 5, 2024, at 11:00 am ET.

How can investors watch KORU Medical's (KRMD) presentation at the Piper Sandler Conference?

Investors can watch the live and archived webcast through the News/Events page in the Investors section of KORU Medical's website at www.korumedical.com.

What is KORU Medical Systems' (KRMD) main business focus?

KORU Medical Systems is a medical technology company focused on developing, manufacturing, and commercializing innovative large volume subcutaneous infusion solutions.

KORU Medical Systems, Inc.

NASDAQ:KRMD

KRMD Rankings

KRMD Latest News

KRMD Stock Data

168.45M
42.95M
6.3%
54.38%
1.06%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
MAHWAH